期刊文献+

中西药联合治疗老年医院内肺炎的疗效 被引量:7

Clinical observation of traditional Chinese medicine combined with western medicine on elderly nosocomical pneumonia
下载PDF
导出
摘要 目的观察抗生素联合喜炎平治疗老年医院内肺炎(NP)的疗效及安全性。方法将48例老年NP患者,随机分为中西药联合组(联合组,n=26)和常规西药组(常规组,n=22),均合理应用抗生素,积极治疗基础疾病、进行营养支持及对症治疗,联合组在此基础上加用喜炎平。结果联合组与常规组有效率分别为96.2%、81.8%,两组比较差异有统计学意义(P<0.05)。联合组退热时间为(72±9)h,常规组为(96±10)h,两组比较差异有统计学意义(P<0.05)。联合组细菌清除率为91.6%,常规组为87.5%,两组比较差异无统计学意义(P>0.05)。两组均未见明显不良反应。结论敏感抗生素联合喜炎平治疗老年NP安全可靠。 Objective To observe the efficacy and safety of antibiotics with Xiyanping on elderly nosocomical pneumonia(NP).Methods 48 elderly NP patients were randomly divided into the traditional Chinese and Western medicine group(combination group,n=26)and conventional Western medicine group(conventional group,n=22),both groups received reasonable application of antibiotics,aggressive treatment of underlying disease,nutritional support and symptomatic treatment,the combination group added Xiyanping on the basis.Results The effective rates of the combination group and conventional group were 96.2% and 81.8%,there was significant difference between the two groups(P0.05).The defervescence time of combination group was(72±9)h,and the conventional group was(96±10)h,there was significant difference between the two groups(P0.05).The bacterial clearance rate of combination group was 91.6%,the conventional group was 87.5%,there was no significant difference between the two groups(P0.05).There was no obvious adverse reaction of the two groups.Conclusion Sensitive antibiotics combined with Xiyanping therapy on elderly NP is safe and reliable,which can improve the success rate of treatment.
作者 兰秋 石振东
出处 《实用药物与临床》 CAS 2012年第6期375-376,共2页 Practical Pharmacy and Clinical Remedies
关键词 医院内肺炎 老年 喜炎平 抗生素 Nosocomial pneumonia Elderly Xiyanping Antibiotics
  • 相关文献

参考文献7

二级参考文献20

  • 1王东浩,王伟,王勇强,曹书华.重症监护病房获得性细菌感染临床调查[J].中华医院感染学杂志,2004,14(2):151-153. 被引量:127
  • 2Rello J,Ollendorf DA,Oster G,et al.Epidemiology and outcomes of ventilator-associated pneumonia in a large US database.Chest,2002,122:2115-2121.
  • 3Johanson WG,Dever LL.Nosocomial pneumonia.Intensive Care Med,2003,29:23-29.
  • 4el-Ebiary M,Torres A,Fabregas N,et al.Significance of the isolation of Candida species from respiratory samples in critically ill,non-neutropenic patients.An immediate postmortem histologic study.Am J Respir Crit Care Med,1997,156(2 Pt 1):583-590.
  • 5Hoffken G,Niederman MS.Nosocomial pneumonia:the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU.Chest,2002,122:2183-2196.
  • 6Dugan HA,MacLaren R,Jung R.Duration of antimicrobial therapy for nosocomial pneumonia:possible strategies for minimizing antimicrobial use in intensive care units.J Clin Pharm Ther,2003,28:123-129.
  • 7Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU[J]. Chest,2002,122(6):2183-2196.
  • 8Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit[J]. Am J Respir Crit Care Med, 2000,162(2):505-511.
  • 9Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System[J]. Crit Care Med,1999, 27(5):887-892.
  • 10Livermore DM. Clinical significance of beta-lactamase induction and stable derepression in Gram-negative rods[J]. Eur J Clin Microbiol, 1987,6(4):439-445.

共引文献2305

同被引文献93

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部